Relmada Therapeutics (RLMD) News Today → It's time to ween off Chinese lithium! (From Smallcaps Daily) (Ad) Free RLMD Stock Alerts $2.95 -0.09 (-2.96%) (As of 06/7/2024 08:52 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative June 6, 2024 | americanbankingnews.comRelmada Therapeutics (NASDAQ:RLMD) Rating Lowered to Sell at The Goldman Sachs GroupJune 5, 2024 | marketbeat.comThe Goldman Sachs Group Downgrades Relmada Therapeutics (NASDAQ:RLMD) to SellThe Goldman Sachs Group downgraded shares of Relmada Therapeutics from a "neutral" rating to a "sell" rating and decreased their price target for the stock from $3.00 to $2.00 in a research note on Wednesday.June 4, 2024 | marketbeat.comRelmada Therapeutics (NASDAQ:RLMD) Trading Up 2.7%Relmada Therapeutics (NASDAQ:RLMD) Stock Price Up 2.7%June 3, 2024 | prnewswire.comRelmada Therapeutics to Participate in the 2024 Jefferies Global Healthcare ConferenceMay 28, 2024 | investorplace.com7 Penny Biotech Stocks to Triple Your InvestmentMay 27, 2024 | finance.yahoo.comRelmada Therapeutics, Inc. (NASDAQ:RLMD) Q1 2024 Earnings Call TranscriptMay 10, 2024 | markets.businessinsider.comBuy Rating Affirmed for Relmada Therapeutics on Strong Clinical Trials and Financial FootingMay 10, 2024 | markets.businessinsider.comBuy Rating for Relmada Therapeutics Supported by Strong Clinical Pipeline and Financial StabilityMay 9, 2024 | finance.yahoo.comQ1 2024 Relmada Therapeutics Inc Earnings CallMay 8, 2024 | msn.comRLMD Stock Earnings: Relmada Therapeutics Beats EPS for Q1 2024May 8, 2024 | prnewswire.comRelmada Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial ResultsMay 7, 2024 | marketbeat.comRelmada Therapeutics (RLMD) Set to Announce Quarterly Earnings on WednesdayRelmada Therapeutics (NASDAQ:RLMD) will be releasing earnings after the market closes on Wednesday, May 8, Zacks reports.May 6, 2024 | prnewswire.comRelmada Therapeutics to Report First Quarter 2024 Financial Results and Host Conference Call and Webcast on May 8, 2024April 23, 2024 | marketbeat.comRelmada Therapeutics (NASDAQ:RLMD) Shares Down 3.3% Relmada Therapeutics (NASDAQ:RLMD) Shares Down 3.3%April 16, 2024 | finance.yahoo.comRELMADA THERAPEUT.DL-,001 (4E2.F)March 21, 2024 | seekingalpha.comRelmada Therapeutics: Run Up Into Results May Resume Following This DropMarch 21, 2024 | markets.businessinsider.comOptimistic Buy Rating for Relmada Therapeutics Amidst Strong Phase 3 Trial Prospects and Financial StabilityMarch 20, 2024 | finance.yahoo.comRelmada Therapeutics, Inc. (NASDAQ:RLMD) Q4 2023 Earnings Call TranscriptMarch 20, 2024 | finanznachrichten.deRelmada Therapeutics, Inc.: Relmada Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2023 Financial ResultsMarch 20, 2024 | finance.yahoo.comQ4 2023 Relmada Therapeutics Inc Earnings CallMarch 19, 2024 | investorplace.comRLMD Stock Earnings: Relmada Therapeutics Misses EPS for Q4 2023March 19, 2024 | benzinga.comRecap: Relmada Therapeutics Q4 EarningsMarch 19, 2024 | finance.yahoo.comRelmada Therapeutics Inc Reports Full-Year and Q4 2023 Financial ResultsMarch 19, 2024 | prnewswire.comRelmada Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2023 Financial ResultsMarch 19, 2024 | msn.comOptions Volatility and Implied Earnings Moves Today, March 19, 2024March 18, 2024 | msn.comRelmada Therapeutics FY 2023 Earnings PreviewMarch 16, 2024 | finance.yahoo.comRLMD Apr 2024 2.500 putMarch 5, 2024 | prnewswire.comRelmada Therapeutics to Participate in the Leerink Partners Global Biopharma ConferenceFebruary 18, 2024 | marketbeat.comSilverarc Capital Management LLC Acquires Shares of 100,000 Relmada Therapeutics, Inc. (NASDAQ:RLMD)Silverarc Capital Management LLC acquired a new stake in shares of Relmada Therapeutics, Inc. (NASDAQ:RLMD - Free Report) during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 100,000 shares of the company's stock,February 13, 2024 | investing.comRelmada Therapeutics Inc (RLMD)February 5, 2024 | markets.businessinsider.comAnalysts Are Bullish on Top Healthcare Stocks: Immunocore Holdings (IMCR), Thermo Fisher (TMO)February 4, 2024 | thestreet.comRelmada Therapeutics Inc.February 2, 2024 | msn.comRelmada Therapeutics And 2 Other Penny Stocks Insiders Are BuyingFebruary 1, 2024 | marketwatch.comRelmada Therapeutics Shares Hit 52-Week High After Execs Buy SharesFebruary 1, 2024 | finance.yahoo.comRelmada Therapeutics Inc CEO Sergio Traversa Acquires 100,000 SharesJanuary 31, 2024 | marketbeat.comFY2024 Earnings Forecast for Relmada Therapeutics, Inc. Issued By Leerink Partnrs (NASDAQ:RLMD)Relmada Therapeutics, Inc. (NASDAQ:RLMD - Free Report) - Analysts at Leerink Partnrs cut their FY2024 earnings per share estimates for shares of Relmada Therapeutics in a note issued to investors on Monday, January 29th. Leerink Partnrs analyst M. Goodman now forecasts that the company will postJanuary 30, 2024 | benzinga.comRelmada Therapeutics Stock (NASDAQ:RLMD) Dividends: History, Yield and DatesJanuary 30, 2024 | marketbeat.comLeerink Partnrs Weighs in on Relmada Therapeutics, Inc.'s FY2028 Earnings (NASDAQ:RLMD)Relmada Therapeutics, Inc. (NASDAQ:RLMD - Free Report) - Investment analysts at Leerink Partnrs issued their FY2028 earnings estimates for shares of Relmada Therapeutics in a research report issued on Monday, January 29th. Leerink Partnrs analyst M. Goodman anticipates that the company will postJanuary 23, 2024 | morningstar.comRelmada Therapeutics Inc RLMDJanuary 23, 2024 | finance.yahoo.comRelmada Therapeutics, Inc.'s (NASDAQ:RLMD) market cap touched US$109m last week, benefiting both individual investors who own 39% as well as institutionsJanuary 4, 2024 | realmoney.thestreet.comMizuho sees weakness in Relmada Therapeutics shares as buying opportunityJanuary 4, 2024 | marketwatch.comRelmada Therapeutics Shares Slide as Medical Chief ExitsJanuary 4, 2024 | finanznachrichten.deRelmada Therapeutics, Inc.: Relmada Therapeutics Provides Corporate UpdateDecember 30, 2023 | marketbeat.comRelmada Therapeutics, Inc. (NASDAQ:RLMD) Short Interest Down 26.2% in DecemberRelmada Therapeutics, Inc. (NASDAQ:RLMD - Get Free Report) saw a large decrease in short interest in the month of December. As of December 15th, there was short interest totalling 638,800 shares, a decrease of 26.2% from the November 30th total of 865,800 shares. Based on an average trading volume of 172,800 shares, the days-to-cover ratio is presently 3.7 days.November 10, 2023 | markets.businessinsider.comBuy Rating for Relmada Therapeutics: Efficient Management, Promising Trials and Prudent Financial ControlNovember 10, 2023 | finance.yahoo.comRelmada Therapeutics, Inc. (NASDAQ:RLMD) Q3 2023 Earnings Call TranscriptNovember 8, 2023 | msn.comRelmada Therapeutics GAAP EPS of -$0.73November 8, 2023 | finance.yahoo.comRelmada Therapeutics Provides Corporate Update and Reports Third Quarter 2023 Financial ResultsNovember 7, 2023 | benzinga.comEarnings Outlook For Relmada TherapeuticsNovember 6, 2023 | finance.yahoo.comPositive Signs As Multiple Insiders Buy Relmada Therapeutics Stock Get Relmada Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for RLMD and its competitors with MarketBeat's FREE daily newsletter. Email Address It's time to ween off Chinese lithium! (Ad)As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promising companies to be watching closely Learn how this American company is leading the lithium-ion revolution RLMD Media Mentions By Week RLMD Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RLMD News Sentiment▼-0.160.76▲Average Medical News Sentiment RLMD News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RLMD Articles This Week▼51▲RLMD Articles Average Week Get Relmada Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for RLMD and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Xeris Biopharma News Neoleukin Therapeutics News Shattuck Labs News Nkarta News Emergent BioSolutions News Alto Neuroscience News FibroBiologics News Atea Pharmaceuticals News UroGen Pharma News Skye Bioscience News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:RLMD) was last updated on 6/10/2024 by MarketBeat.com Staff From Our PartnersIt's time to ween off Chinese lithium!As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promi...Smallcaps Daily | SponsoredWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredRSVP: Charles Payne’s Cash Flow WorkshopDid you know you could "cash flow" the stocks in your portfolio? Without selling a single share of stock? ...Unstoppable Prosperity | SponsoredNvidia needs this one obscure firm In my new investigation, I detail why this is the single most important factor in the future of AI. I expla...Porter & Company | SponsoredBuy this small stock before coming AI Tidal WaveThe internet generated more wealth than any other innovation in history - creating hundreds of thousands of ne...Chaikin Analytics | SponsoredTime is Running Out - June 25th Deadline Approaching!Today, I’m making my boldest prediction ever. Next-generation AI technology will create the first $100 TRIL...Paradigm Press | SponsoredAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredMoonshot Coins for the Current Crypto RunDid you see bitcoin crossed $70k again? Don't miss the next bull run. Because while Bitcoin and Ethereum s...Crypto 101 Media | Sponsored